Reboli is a Professor of Medicine and the Dean of Cooper Medical School of Rowan University in Camden. She is the Chief Academic Officer with ultimate responsibility for all areas of the school. Previously, she was founding vice dean responsible for oversight of the LCME accreditation process, undergraduate and graduate medical education, faculty affairs and faculty development, and developing affiliations for the medical school.
Reboli received a Bachelor of Science degree with a major in Biology from Georgetown University College of Arts and Sciences in Washington, DC. She received her MD degree cum laude from Georgetown University School of Medicine and was elected to the Alpha Omega Alpha Honor Medical Society during medical school. She completed an internship, residency, and a year as Chief Medical Resident in Internal Medicine at Georgetown University Medical Center in Washington, D.C., followed by a three-year clinical and research fellowship in infectious diseases at the Medical University of South Carolina in Charleston, South Carolina.
She also served as Interim Dean of CMSRU and was the Head of the Division of Infectious Diseases and the Deputy Chief for Administration of the Department of Medicine at Cooper University Hospital in Camden, where she also served as the hospital epidemiologist.
During her tenure as division head of infectious diseases, she established a comprehensive clinical research program that led the Department of Medicine in external funding. Reboli also served as a consultant to Janssen, Vicuron, Pfizer, and Merck Pharmaceutical Company on antimicrobial drug development and clinical trial design.
She has authored or co-authored over 180 peer-reviewed publications, book chapters, and abstracts. Reboli has been named a “Top Doctor” in a variety of magazines, including New Jersey Monthly, Philadelphia Magazine, South Jersey Magazine, SJ Magazine, and Consumer’s Checkbook. Reboli’s main research interest is in candidemia and other forms of invasive candidiasis. Over the course of her career, she has garnered over $15 million in research support from a variety of sources, including NIH, NIAID, HRSA, private foundations, and private industry. In 2008, she received the Robert Wood Johnson Medical School Dean’s Research Award in the faculty-clinical sciences category for research on antifungal therapy that was published in the New England Journal of Medicine.
More from the 2019 NJBIZ Education Power 50: